TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 4 | 10 | 22 | 7 | 11 | 19 | 36 | 17 |
| P | %wins | 100 | 100 | 50 | 50 | 50 | 75 | 71 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/8/14 21:29 | 5/7/14 | SCYX | Scynexis Inc | DE | Health | Drug | Pharmaceutical Preparations | Alta Biopharma Partners II LP | CA | T | P.d | 9,000 | 10.00 | 2 | 900 | 233 | 1,286 | M | -4 | 5 | 2 | -6 | -30 | -3 | 9 | ||||||||
10/20/09 18:56 | 10/16/09 | CORT | Corcept Therapeutics Inc | Health | Drug | Pharmaceutical Preparations | Alta Biopharma Partners II LP | CA | T | P.ad | 483 | 1.38 | 0 | 350 | 7 | 5,664 | M | -55 | 57 | 86 | 99 | 57 | 23 | 27 | 7 | 15 | 39 | 18 | 53 | 64 | 100 | ||
10/20/09 17:13 | 10/16/09 | CORT | Corcept Therapeutics Inc | Health | Drug | Pharmaceutical Preparations | Alta Biopharma Partners II LP | CA | T | P.d | 483 | 1.38 | 0 | 350 | 7 | 5,664 | M | -55 | 57 | 86 | 99 | 57 | 23 | 27 | 7 | 15 | 39 | 18 | 53 | 64 | 100 | ||
3/26/08 17:53 | 3/25/08 | CORT | Corcept Therapeutics Inc | Health | Drug | Pharmaceutical Preparations | Alta Biopharma Partners II LP | CA | T | P.d | 2,934 | 2.77 | 0 | 1,059 | 166 | I | -44 | 242 | -41 | 3 | 1 | 12 | 7 | 4 | 6 | 9 | -2 | -32 | -50 | -67 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |